{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:07:24Z","timestamp":1771488444975,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.drugalcdep.2014.06.013","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T14:46:34Z","timestamp":1403189194000},"page":"139-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine\/naloxone in HIV-negative injection opioid users in China and Thailand"],"prefix":"10.1016","volume":"142","author":[{"given":"Gregory M.","family":"Lucas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apinun","family":"Aramrattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Celentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Brooks","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0376-8716(00)00141-1","article-title":"Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans","volume":"61","author":"Amass","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-8278(00)00050-7","article-title":"Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation","volume":"34","author":"Berson","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0168-8278(00)00049-0","article-title":"Hepatitis after intravenous buprenorphine misuse in heroin addicts","volume":"34","author":"Berson","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/ADM.0b013e3181c4e27e","article-title":"Effects of buprenorphine and hepatitis C on liver enzymes in adolescents and young adults","volume":"4","author":"Bogenschutz","year":"2010","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/00042737-200410000-00013","article-title":"Acute hepatitis due to buprenorphine administration","volume":"16","author":"Herve","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.06.013_bib0035","first-page":"29","article-title":"Hepatonephritis and massive ingestion of buprenorphine","author":"Houdret","year":"1999","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugpo.2011.06.005","article-title":"Short-term safety of buprenorphine\/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058","volume":"23","author":"Lucas","year":"2011","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0045","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.dld.2005.03.009","article-title":"Liver enzyme values in injection drug users with chronic hepatitis C","volume":"37","author":"Mehta","year":"2005","journal-title":"Digest. Liver Dis."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0055","series-title":"19th International AIDS Conference","article-title":"One year of counseling supported buprenorphine\u2013naloxone treatment for HIV prevention in opiate dependent injecting drug users showed efficacy in reducing opiate use and injection frequency: HPTN 058 in Thailand and China [Abstract THPE191]","author":"Metzger","year":"2012"},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/10550490050148099","article-title":"Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine","volume":"9","author":"Petry","year":"2000","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2012.08.002","article-title":"Buprenorphine\/naloxone and methadone effects on laboratory indices of liver health: a randomized trial","volume":"128","author":"Saxon","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0070","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0006-3223(99)00270-X","article-title":"Thrice-weekly versus daily buprenorphine maintenance","volume":"47","author":"Schottenfeld","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0075","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7326\/0003-4819-148-9-200805060-00006","article-title":"Narrative review: buprenorphine for opioid-dependent patients in office practice","volume":"148","author":"Sullivan","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0080","series-title":"Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939","article-title":"Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction","author":"Substance Abuse and Mental Health Services Administration","year":"2004"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.06.013_bib0085","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/QAI.0b013e31820a820f","article-title":"Hepatic safety and lack of antiretroviral interactions with buprenorphine\/naloxone in HIV-infected opioid-dependent patients","volume":"56","author":"Vergara-Rodriguez","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.06.013_bib0090","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.dld.2007.12.014","article-title":"Acute liver and renal failure during treatment with buprenorphine at therapeutic dose","volume":"41","author":"Zuin","year":"2009","journal-title":"Digest. Liver Dis."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614009211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614009211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T02:58:47Z","timestamp":1538535527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614009211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":18,"alternative-id":["S0376871614009211"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.06.013","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine\/naloxone in HIV-negative injection opioid users in China and Thailand","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}